[Real-life data of the IVI interval after switching to faricimab therapy].

Muranyi DS, Molling J, Hammer U, Habermann A, Lehmann G, Luci E, Buchwald C, Hammer T.

DOI: 10.1007/s00347-026-02389-w
Published: 2026-02-06
Container: Ophthalmologie
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00347-026-02389-w,
  title = {[Real-life data of the IVI interval after switching to faricimab therapy].},
  author = {Muranyi DS and  Molling J and  Hammer U and  Habermann A and  Lehmann G and  Luci E and  Buchwald C and  Hammer T.},
  year = {2026},
  journal = {Ophthalmologie},
  doi = {10.1007/s00347-026-02389-w},
  url = {https://doi.org/10.1007/s00347-026-02389-w}
}

RIS

TY  - JOUR
TI  - [Real-life data of the IVI interval after switching to faricimab therapy].
AU  - Muranyi DS
AU  -  Molling J
AU  -  Hammer U
AU  -  Habermann A
AU  -  Lehmann G
AU  -  Luci E
AU  -  Buchwald C
AU  -  Hammer T.
PY  - 2026
JO  - Ophthalmologie
DO  - 10.1007/s00347-026-02389-w
UR  - https://doi.org/10.1007/s00347-026-02389-w
ER  -

APA

DS, M., J, M., U, H., A, H., G, L., E, L., C, B., & T., H. (2026). [Real-life data of the IVI interval after switching to faricimab therapy].. Ophthalmologie. https://doi.org/10.1007/s00347-026-02389-w

Source records

europe-pmc · retrieved 2026-09-27T09:53:10.963Z